Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,243,411
+$1,646,215 QoQ
Shares Held
528,520
-15.9% QoQ
Ownership
0.908%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 328 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. HRMY ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in HRMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,243,411 | 528,520 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,597,196 | 628,247 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $16,869,120 | 450,805 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $11,114,613 | 403,288 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,669,922 | 400,947 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $14,725,967 | 443,687 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,456,282 | 449,180 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,560,960 | 164,024 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,553,675 | 150,934 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,496,628 | 133,908 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,687,882 | 114,176 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,143,536 | 126,443 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,188,024 | 147,429 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $31,158,905 | 954,331 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $92,335,256 | 1,675,776 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $51,807,562 | 1,169,735 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,683,027 | 260,058 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $9,842,282 | 202,308 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,705,791 | 110,361 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $362,562 | 9,459 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $213,079 | 7,548 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||